192 related articles for article (PubMed ID: 36600486)
1. Dysregulation of metalloproteinases in spinal ligament degeneration.
Wang C; Wei Z; Yu T; Zhang L
Connect Tissue Res; 2023 Jul; 64(4):310-322. PubMed ID: 36600486
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
4. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
5. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
7. Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement.
Liva F; Cuffaro D; Nuti E; Nencetti S; Orlandini E; Vozzi G; Rossello A
Curr Drug Targets; 2019; 20(9):903-918. PubMed ID: 30666909
[TBL] [Abstract][Full Text] [Related]
8. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
10. MMPs and ADAMTSs in intervertebral disc degeneration.
Wang WJ; Yu XH; Wang C; Yang W; He WS; Zhang SJ; Yan YG; Zhang J
Clin Chim Acta; 2015 Aug; 448():238-46. PubMed ID: 26162271
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.
Yang CY; Chanalaris A; Troeberg L
Osteoarthritis Cartilage; 2017 Jul; 25(7):1000-1009. PubMed ID: 28216310
[TBL] [Abstract][Full Text] [Related]
12. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinases in extracellular vesicles.
Shimoda M; Khokha R
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1989-2000. PubMed ID: 28578911
[TBL] [Abstract][Full Text] [Related]
14. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin.
Pérez-García S; Carrión M; Gutiérrez-Cañas I; Villanueva-Romero R; Castro D; Martínez C; González-Álvaro I; Blanco FJ; Juarranz Y; Gomariz RP
Cells; 2019 Dec; 9(1):. PubMed ID: 31877874
[TBL] [Abstract][Full Text] [Related]
15. Development of Matrix Metalloproteinases-Mediated Extracellular Matrix Remodeling in Regenerative Medicine: A Mini Review.
Chen K; Xu M; Lu F; He Y
Tissue Eng Regen Med; 2023 Aug; 20(5):661-670. PubMed ID: 37160567
[TBL] [Abstract][Full Text] [Related]
16. Structure and Function of Human Matrix Metalloproteinases.
Laronha H; Caldeira J
Cells; 2020 Apr; 9(5):. PubMed ID: 32357580
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
